Legacy of Drug Patenting and Its Impact on Public Health

New drugs extend life and improve its quality. Drug patents provide an incentive to develop new drugs, but patented drugs are often expensive, and they block the sale of inexpensive generic copies. Generic firms have grown active in challenging the validity of drug patents over the past two decades, in an effort to enter the market prior to expiration of the patent. This paper examines these legal challenges and their effects on the entry of generic drugs and access to medicines. These analyses will help us to inform current policy debates about how well pharmaceutical patent laws and regulations balance innovation and access, and their effect on public health.

Authors

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2026-11-21
DOI
https://doi.org/10.5281/zenodo.24413927
Primary Topic
Pharmaceutical Economics and Policy
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Legacy of Drug Patenting and Its Impact on Public Health

Dr. Imran Ahad
Zenodo (CERN European Organization for Nuclear Research)
Pharmaceutical Economics and Policy
article

Legacy of Drug Patenting and Its Impact on Public Health

Dr. Imran Ahad
article en

Abstract

New drugs extend life and improve its quality. Drug patents provide an incentive to develop new drugs, but patented drugs are often expensive, and they block the sale of inexpensive generic copies. Generic firms have grown active in challenging the validity of drug patents over the past two decades, in an effort to enter the market prior to expiration of the patent. This paper examines these legal challenges and their effects on the entry of generic drugs and access to medicines. These analyses will help us to inform current policy debates about how well pharmaceutical patent laws and regulations balance innovation and access, and their effect on public health.

Zenodo (CERN European Organization for Nuclear Research)
Central University of Kashmir (IN)
Pharmaceutical Economics and Policy
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon